FHC
SGMO

First Horizon Corporation’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

First Horizon Corporation’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$0 Hold
41
– – ﹤0.01% 1191
2021
Q1 		$0 Hold
41
– – ﹤0.01% 1198
2020
Q4 		$0 Hold
41
– – ﹤0.01% 1214
2020
Q3 		$0 Buy
+41
New +$443 ﹤0.01% 1157

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Horizon Corporation's SGMO Position: Q2 2021 in Review

First Horizon Corporation held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q2 2021 at 41 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1191.

First Horizon Corporation first reported a position in SGMO in Q3 2020 and has held it in 4 quarters since. 197 funds tracked by Wall St. Rank hold SGMO as of Q2 2021.

  • First Horizon Corporation held 41 shares of SANGAMO THERAPEUTICS INC worth $0 as of Q2 2021.
  • First Horizon Corporation left its SANGAMO THERAPEUTICS INC share count unchanged in Q2 2021.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2021, its #1191 holding.
  • First Horizon Corporation first reported a position in SANGAMO THERAPEUTICS INC in Q3 2020 and has held it in 4 quarters since.
  • 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2021.

Based on First Horizon Corporation's 13F filing for Q2 2021, filed 9 Aug 2021.